Advertisements



Revance Therapeutics is Now Oversold (RVNC)

Dividend Channel.....»»

Category: topSource: redinewsSep 14th, 2018

Revance Therapeutics Becomes Oversold (RVNC)

Dividend Channel.....»»

Category: topSource: redinewsJan 28th, 2019

Revance Therapeutics (RVNC) Investor Presentation - Slideshow

Revance Therapeutics (RVNC) Investor Presentation - Slideshow.....»»

Category: topSource: seekingalphaJun 11th, 2019

Revance Therapeutics, Inc. (RVNC) on Q1 2019 Results - Earnings Call Transcript

Revance Therapeutics, Inc. (RVNC) on Q1 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 9th, 2019

Revance Therapeutics" (RVNC) CEO Dan Browne on Q1 2018 Results - Earnings Call Transcript

Revance Therapeutics" (RVNC) CEO Dan Browne on Q1 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 12th, 2018

Revance Therapeutics (RVNC) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsJun 22nd, 2018

Revance Therapeutics" (RVNC) CEO Dan Browne on Q2 2018 Results - Earnings Call Transcript

Revance Therapeutics" (RVNC) CEO Dan Browne on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 4th, 2018

JMP: Changing Competitive Landscape Makes Revance Less Appealing

Revance Therapeutics Inc (NASDAQ: RVNC), a biotech company developing a botulinum toxin product,¬†could face a competitive backlash, according to JMP Securities. Latest Ratings for RVNC Dat.....»»

Category: blogSource: benzingaSep 17th, 2018

Revance Therapeutics, Inc. (RVNC) CEO Daniel Browne on Q3 2018 Results - Earnings Call Transcript

Revance Therapeutics, Inc. (RVNC) CEO Daniel Browne on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 2nd, 2018

Revance Therapeutics, Inc. (RVNC) CEO Daniel Browne on Q4 2018 Results - Earnings Call Transcript

Revance Therapeutics, Inc. (RVNC) CEO Daniel Browne on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaFeb 26th, 2019

Revance Therapeutics Inc (RVNC) Files 10-K for the Fiscal Year Ended on December 31, 2018

Related Stocks: RVNC,.....»»

Category: blogSource: gurufocusMar 1st, 2019

Aldeyra Therapeutics Becomes Oversold (ALDX)

Dividend Channel.....»»

Category: topSource: redinews19 hr. 30 min. ago

CymaBay Therapeutics Becomes Oversold (CBAY)

Dividend Channel.....»»

Category: topSource: redinewsJul 13th, 2019

RSI Alert: Abeona Therapeutics (ABEO) Now Oversold

Dividend Channel.....»»

Category: topSource: redinewsJul 3rd, 2019

Menlo Therapeutics is Now Oversold (MNLO)

Dividend Channel.....»»

Category: topSource: redinewsJun 27th, 2019

RSI Alert: Spark Therapeutics (ONCE) Now Oversold

Dividend Channel.....»»

Category: topSource: redinewsJun 10th, 2019

Orchard Therapeutics is Now Oversold (ORTX)

Dividend Channel.....»»

Category: topSource: redinewsJun 5th, 2019

Abeona Therapeutics Becomes Oversold (ABEO)

Dividend Channel.....»»

Category: topSource: redinewsMay 28th, 2019

Neos Therapeutics Enters Oversold Territory

Neos Therapeutics has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. Want the latest recommendations from Zacks .....»»

Category: smallbizSource: nytMay 24th, 2019

ASSERTIO THERAPEUTICS Enters Oversold Territory

ASSERTIO THERAPEUTICS has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. Want the latest.....»»

Category: worldSource: nytMay 20th, 2019

Oversold Conditions For Akebia Therapeutics

Dividend Channel.....»»

Category: topSource: redinewsMay 1st, 2019